- Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
- 2 Biotech Companies With Strong Product Launches To Monitor
- Profits Can Be Found In The Expanding And Challenging Medical Isotope Business
- 3 Contenders With Novel, Non-Invasive Treatments For Cancer
- Biotechnology Super Panel Talks Development, Marketing And The Future
The Swiss Trader
The Swiss Trader
Stop FollowingThe Swiss Trader
ABOUT
As an avid stock trader I am always searching for new opportunities. I utilize a very research heavy approach in my strategy that has done quite well for me over the years. I have earned a degree in Physics and an MBA in Finance. Although my educational background is an unconventional pairing, both have served me well. I am currently a consultant that specializes in small business development.
SNAPSHOT
- Description: Occasional investor. Trading frequency: Weekly
- Interests: Options, Stocks - long, Stocks - short, Tech stocks
COMPANY
Currently, there is no company profile for The Swiss Trader.
BLOG
Currently, there are no blog details for The Swiss Trader.
Book
Currently, there are no book details for The Swiss Trader.
Latest Comments
more »
- I did not hear his comments... on Stem Cell Companies For Consideration In 2013
- The warrants are $1.90. The... on Galena Removes Financing Risk
- It won't complete Phase 3 t... on Galena Removes Financing Risk
- It wants to raise $24 milli... on Galena Removes Financing Risk
- I have heard no such detail... on Galena Removes Financing Risk
Latest comments on The Swiss's Articles
- John H. Crawford on 2 Biotech Companies With Strong Product Launche...
- Jellowilly on 2 Biotech Companies With Strong Product Launche...
- carsons7 on 2 Biotech Companies With Strong Product Launche...
- tikigod18 on Buy Low, Sell High - Apache Is Undervalued At U...
- roblites on 3 Contenders With Novel, Non-Invasive Treatment...
LATEST ARTICLES & INSTAPOSTS
more »
